Lion Biotechnologies CSO Laszlo Radvanyi Co-Authors Study in Journal of Immunotherapy
October 20, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies to Present at the Rodman & Renshaw 16th Annual Global Investment Conference
September 05, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, Sept. 5, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based...
Lion Biotechnologies Names Elma Hawkins President and Chief Operating Officer
August 20, 2014 16:05 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, Aug. 20, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies' Chief Scientific Officer to Present at Immunotherapies and Vaccines Summit
August 11, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, Aug. 11, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies Enters Clinical Trial Grant Agreement With Moffitt Cancer Center
July 30, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, July 30, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies Announces Exclusive License Agreement With Moffitt Cancer Center
July 25, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, July 25, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies Leases New Research Laboratory
July 23, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, July 23, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies Appoints Dr. Laszlo Radvanyi as Chief Scientific Officer
June 23, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, June 23, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...
Lion Biotechnologies to Present at the Jefferies 2014 Global Healthcare Conference
May 27, 2014 08:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, May 27, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCQB:LBIO), a biotechnology company focused on the development and commercialization of novel cancer immunotherapies based on...
Lion Biotechnologies' Lead Program With National Cancer Institute Demonstrates Positive Results in Patients With Stage 4 Metastatic Melanoma
April 07, 2014 12:00 ET
|
Lion Biotechnologies, Inc.
LOS ANGELES, April 7, 2014 (GLOBE NEWSWIRE) -- Lion Biotechnologies, Inc. (OTCBB:LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor infiltrating lymphocytes...